In patients aged over 70, the predictive ability of the FIB‐3 index for 5‐year OS showed a trend toward superiority ( p = 0.06), whereas the predictive performance for RFS was nearly identical between the two indices (Figure 5B,F ).
Patients with viral sepsis showed a trend of having lower LIGHT levels than patients with bacterial sepsis, albeit not statistically different ( p = 0.060).
Years from initial diagnosis showed a trend to being fewer in those with moderate versus mild impairment (26 v 23 years, p = 0.06).
After matching, FPDMM‐AML patients again showed a trend toward a favorable outcome, albeit without statistical significance ( p = 0.06) (Figure 5F ).
LBD status, however, showed a trend toward higher frequency in those with higher NFT stage ( p = 0.06), accompanied by a shift toward more advanced LBD stages.
In addition, although not significant, higher CD40L showed a trend of association with lower odds (estimated odds ratio 0.56, p -value = 0.06) of being classified as early decliners in the executive function domain.
Functional Connectivity NBS analysis did not show differences in functional connectivity in ALS groups relative to controls, although patients with ALS-ci/bi showed a trend toward an enhanced functional connectivity relative to controls within frontal and basal ganglia areas ( p = 0.06).
The ANOVA for the length of fingers showed a trend for the Distance factor [ F (1,18) = 4.01, p = 0.06, η p 2 = 0.18], as there was an overall reduction of the underestimation in the far-reaching space condition.
165 ± 37 kcal/day; P = 0.02) while children in the technology group showed a trend for a significant increase in calories consumed from savory snacks over the course of the intervention (286 ± 43 kcal/day vs. 439 ± 61 kcal/day; P = 0.06; Group*Time: P = 0.007).
Compression garment discontinuation showed a trend toward improvement with scar release (52% vs. 42%, p = 0.06) ( Figure 5 ). 3.6.
However, changes in overall Bern-scores did not correlate with clinical variables, although brain sagging showed a trend toward correlation with headache intensity reduction ( r = 0.37, p = 0.06).
Although the difference was not statistically significant, patients with increased CRP also showed a trend of FDG accumulation in ≥ 2 cartilages ( p = 0.06).
For the testing day, however, the aged AMPKα1 cKO mice showed a trend of improved fear learning/memory compared to the aged Cre+/- group ( p =0.06).
With no receptor inhibitions, moDCs showed a trend towards a significant decrease in IFNβ production when treated with lenabasum [20.7% (20.6–25) to 10.2% (8.57–10.9); p = 0.06 ] (Fig. 3 c).
Higher pre-FLOT SMI (HR: 0.95, p = 0.09) and tumors in the GEJ ( versus stomach, HR: 0.34, p = 0.07) showed a trend towards superior PFS whereas pre-FLOT sarcopenia ( versus no sarcopenia, HR: 2.83, p = 0.06; Fig. 1 b) showed a trend towards inferior PFS.
Serum IL-6 levels showed a trend toward reduction after treatment (pre-treatment 1.75 [1.02–2.23] pg/mL vs post-treatment 0.92 [0.26–2.36] pg/mL; P = 0.06 ).
Specifically, the CM group showed a trend toward right-lateralized IFG activation during the pretest ( p = 0.06; Hedge’s g = 0.60; 87.5% of the children followed this trend) and bilaterally symmetrical cortical activation across all ROIs during the post-test ( p s > 0.05; Figure 8 A; Supplementary Table S8 ).
Those with stroke showed a trend of a longer median follow-up period compared with those without stroke [9.00 years (IQR 5.50, 12.00) vs 6.00 (2.00–10.00), P = 0.06].
The relative abundance of serine protease showed a trend toward a lower level in IBS compared to HC ( p = 0.06).
However, DBP showed a trend toward association with postoperative hypertension (DBP: OR = 1.17, 95% CI: 0.99–1.38, P = 0.06, I 2 = 30%), approaching but not meeting our predefined significance threshold (P < 0.05).
At baseline, patients with severe PASI (>10) showed a trend toward higher expression of CXCL10 ( p = 0.060) and CXCL9 ( p = 0.060) in NL skin compared to those with mild PASI (≤10) ( Figure 2 D).
Additionally, the TRG‐5 group showed a trend of having higher NRF2 nuclear positivity scores in post‐NACT specimens compared to the TRG‐3 + 4 group (median 100.0 versus 0.0, p = 0.060).
CRT significantly reduced local progression rates (32% versus 46%, p = 0.030) and showed a trend towards better median PFS (9.9 versus 8.4 months, p = 0.060) and longer median time without retreatment (6.1 versus 3.7 months, p = 0.020).
Feed efficiency showed a trend with treatment-age interaction ( p = 0.06).
Female but not male wild type mice injected with Dox showed a trend to reduced total fat mass (expressed as a percent of body weight) (p = 0.06) ( Figure 4A, 4B ).